Results 291 to 300 of about 5,474,833 (393)
The bottom‐up strategy based on multiomics data is used for the SynCom design, and it successfully inhibited F. nucleatum growth and achieved stable colonization in vivo. In addition, it promoted tryptophan metabolism and secondary bile acid conversion, reduced lipid accumulation, relieved microbiome disorder, decreased inflammatory reaction, and ...
Zhongkun Zhou+11 more
wiley +1 more source
In vivo and in vitro characterization of colorectal cancer cells [PDF]
C.P.H.J. Verstijnen
openalex +1 more source
Fusobacterium nucleatum is enriched in invasive biofilms in colorectal cancer. [PDF]
Queen J+14 more
europepmc +1 more source
MYC is a transcription factor (TF) that binds DNA near transcriptional start sites (TSSs) and within enhancer elements. Here, unappreciated sites of MYC binding in the vicinity of transcriptional end sites (TESs) of many genes in multiple cell types in association with numerous other TFs are described previously.
Huabo Wang+5 more
wiley +1 more source
Sugar, fat, and the risk of colorectal cancer [PDF]
J. V. G. A. Durnin
openalex +1 more source
The TIP60-CD44 Axis Modulates Colorectal Cancer Stemness. [PDF]
Mohammad A, Jha S.
europepmc +1 more source
Based on IP‐MS analysis, BAG2 is confirmed to be essential for ubiquitination and protein homeostasis regulation of STING in cervical cancer. BAG2 inhibits the ubiquitination and degradation of STING by forming a complex with STUB1, thereby activating the type I IFN signaling pathway and inhibiting the development of cervical cancer.
Shijie Yao+6 more
wiley +1 more source
Long-time infusion of sequential methotrexate and 5-fluorouracil in the treatment of advanced colorectal cancer [PDF]
E. J. Borghardi+3 more
openalex +1 more source